"","title","geo_accession","status","submission_date","last_update_date","type","channel_count","source_name_ch1","organism_ch1","characteristics_ch1","characteristics_ch1.1","characteristics_ch1.2","characteristics_ch1.3","characteristics_ch1.4","characteristics_ch1.5","characteristics_ch1.6","characteristics_ch1.7","characteristics_ch1.8","characteristics_ch1.9","molecule_ch1","extract_protocol_ch1","label_ch1","label_protocol_ch1","taxid_ch1","hyb_protocol","scan_protocol","data_processing","platform_id","contact_name","contact_email","contact_department","contact_institute","contact_address","contact_city","contact_zip/postal_code","contact_country","supplementary_file","data_row_count"
"GSM794865","serous ovarian cancer 10d","GSM794865","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 3","Stage: IIIc","surgery status: optimal","taxane: 1","platinum: 1","pfs (m): 79","rec (1): 0","os (m): 79","death (1): 0","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM794nnn/GSM794865/GSM794865_s10d.txt.gz","41093"
"GSM794866","serous ovarian cancer 11d","GSM794866","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 2","Stage: IIIb","surgery status: optimal","taxane: 1","platinum: 1","pfs (m): 46","rec (1): 1","os (m): 76","death (1): 0","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM794nnn/GSM794866/GSM794866_s11d.txt.gz","41093"
"GSM794867","serous ovarian cancer 115d","GSM794867","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 3","Stage: IIIb","surgery status: suboptimal","taxane: 1","platinum: 1","pfs (m): 12","rec (1): 1","os (m): 69","death (1): 1","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM794nnn/GSM794867/GSM794867_s115d.txt.gz","41093"
"GSM794868","serous ovarian cancer 116d","GSM794868","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 2","Stage: IIIc","surgery status: suboptimal","taxane: 1","platinum: 1","pfs (m): 14","rec (1): 1","os (m): 51","death (1): 1","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM794nnn/GSM794868/GSM794868_s116d.txt.gz","41093"
"GSM794869","serous ovarian cancer 117d","GSM794869","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 3","Stage: IIIc","surgery status: optimal","taxane: 1","platinum: 1","pfs (m): 18","rec (1): 1","os (m): 38","death (1): 0","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM794nnn/GSM794869/GSM794869_s117d.txt.gz","41093"
"GSM794870","serous ovarian cancer 119d","GSM794870","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 3","Stage: IIIc","surgery status: optimal","taxane: 1","platinum: 1","pfs (m): 40","rec (1): 0","os (m): 40","death (1): 0","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM794nnn/GSM794870/GSM794870_s119d.txt.gz","41093"
"GSM794871","serous ovarian cancer 12d","GSM794871","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 3","Stage: IIIc","surgery status: optimal","taxane: 1","platinum: 1","pfs (m): 8","rec (1): 1","os (m): 24","death (1): 1","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM794nnn/GSM794871/GSM794871_s12d.txt.gz","41093"
"GSM794872","serous ovarian cancer 120d","GSM794872","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 2","Stage: IV","surgery status: suboptimal","taxane: 1","platinum: 1","pfs (m): 6","rec (1): 1","os (m): 52","death (1): 1","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM794nnn/GSM794872/GSM794872_s120d.txt.gz","41093"
"GSM794873","serous ovarian cancer 122d","GSM794873","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 2","Stage: IIIc","surgery status: suboptimal","taxane: 1","platinum: 1","pfs (m): 8","rec (1): 1","os (m): 25","death (1): 1","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM794nnn/GSM794873/GSM794873_s122d.txt.gz","41093"
"GSM794874","serous ovarian cancer 123d","GSM794874","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 2","Stage: IIIc","surgery status: suboptimal","taxane: 1","platinum: 1","pfs (m): 15","rec (1): 1","os (m): 22","death (1): 1","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM794nnn/GSM794874/GSM794874_s123d.txt.gz","41093"
"GSM794875","serous ovarian cancer 125Rd","GSM794875","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 2","Stage: IV","surgery status: suboptimal","taxane: 1","platinum: 1","pfs (m): 10","rec (1): 1","os (m): 31","death (1): 1","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM794nnn/GSM794875/GSM794875_s125Rd.txt.gz","41093"
"GSM794876","serous ovarian cancer 129d","GSM794876","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 2","Stage: IIIc","surgery status: optimal","taxane: 1","platinum: 1","pfs (m): 12","rec (1): 1","os (m): 13","death (1): 1","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM794nnn/GSM794876/GSM794876_s129d.txt.gz","41093"
"GSM794877","serous ovarian cancer 130d","GSM794877","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 2","Stage: IIIc","surgery status: suboptimal","taxane: 1","platinum: 1","pfs (m): 25","rec (1): 1","os (m): 99","death (1): 0","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM794nnn/GSM794877/GSM794877_s130d.txt.gz","41093"
"GSM794878","serous ovarian cancer 132d","GSM794878","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 3","Stage: IIIc","surgery status: optimal","taxane: 1","platinum: 1","pfs (m): 36","rec (1): 1","os (m): 93","death (1): 0","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM794nnn/GSM794878/GSM794878_s132d.txt.gz","41093"
"GSM794879","serous ovarian cancer 134d","GSM794879","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 2","Stage: IIIa","surgery status: optimal","taxane: 1","platinum: 1","pfs (m): 30","rec (1): 1","os (m): 62","death (1): 1","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM794nnn/GSM794879/GSM794879_s134d.txt.gz","41093"
"GSM794880","serous ovarian cancer 139d","GSM794880","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 3","Stage: IIIc","surgery status: optimal","taxane: 1","platinum: 1","pfs (m): 35","rec (1): 1","os (m): 65","death (1): 0","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM794nnn/GSM794880/GSM794880_s139d.txt.gz","41093"
"GSM794881","serous ovarian cancer 140d","GSM794881","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 3","Stage: IV","surgery status: suboptimal","taxane: 1","platinum: 1","pfs (m): 14","rec (1): 1","os (m): 28","death (1): 1","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM794nnn/GSM794881/GSM794881_s140d.txt.gz","41093"
"GSM794882","serous ovarian cancer 143d","GSM794882","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 3","Stage: IIIc","surgery status: suboptimal","taxane: 1","platinum: 1","pfs (m): 6","rec (1): 1","os (m): 39","death (1): 0","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM794nnn/GSM794882/GSM794882_s143d.txt.gz","41093"
"GSM794883","serous ovarian cancer 144d","GSM794883","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 2","Stage: IV","surgery status: suboptimal","taxane: 1","platinum: 1","pfs (m): 26","rec (1): 1","os (m): 52","death (1): 0","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM794nnn/GSM794883/GSM794883_s144d.txt.gz","41093"
"GSM794884","serous ovarian cancer 145d","GSM794884","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 3","Stage: IIIc","surgery status: suboptimal","taxane: 1","platinum: 1","pfs (m): 24","rec (1): 1","os (m): 49","death (1): 0","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM794nnn/GSM794884/GSM794884_s145d.txt.gz","41093"
"GSM794885","serous ovarian cancer 146d","GSM794885","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 3","Stage: IIIb","surgery status: suboptimal","taxane: 1","platinum: 1","pfs (m): 44","rec (1): 0","os (m): 44","death (1): 0","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM794nnn/GSM794885/GSM794885_s146d.txt.gz","41093"
"GSM794886","serous ovarian cancer 148d","GSM794886","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 3","Stage: IIIc","surgery status: optimal","taxane: 1","platinum: 1","pfs (m): 24","rec (1): 1","os (m): 35","death (1): 0","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM794nnn/GSM794886/GSM794886_s148d.txt.gz","41093"
"GSM794887","serous ovarian cancer 15d","GSM794887","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 3","Stage: IIIb","surgery status: optimal","taxane: 1","platinum: 1","pfs (m): 18","rec (1): 1","os (m): 71","death (1): 0","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM794nnn/GSM794887/GSM794887_s15d.txt.gz","41093"
"GSM794888","serous ovarian cancer 150d","GSM794888","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 2","Stage: IIIc","surgery status: suboptimal","taxane: 1","platinum: 1","pfs (m): 31","rec (1): 1","os (m): 35","death (1): 0","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM794nnn/GSM794888/GSM794888_s150d.txt.gz","41093"
"GSM794889","serous ovarian cancer 155d","GSM794889","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 3","Stage: IIIb","surgery status: optimal","taxane: 1","platinum: 1","pfs (m): 28","rec (1): 0","os (m): 28","death (1): 0","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM794nnn/GSM794889/GSM794889_s155d.txt.gz","41093"
"GSM794890","serous ovarian cancer 156d","GSM794890","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 3","Stage: IIIc","surgery status: optimal","taxane: 1","platinum: 1","pfs (m): 42","rec (1): 0","os (m): 42","death (1): 0","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM794nnn/GSM794890/GSM794890_s156d.txt.gz","41093"
"GSM794891","serous ovarian cancer 16d","GSM794891","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 2","Stage: IIIc","surgery status: optimal","taxane: 1","platinum: 1","pfs (m): 13","rec (1): 1","os (m): 71","death (1): 0","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM794nnn/GSM794891/GSM794891_s16d.txt.gz","41093"
"GSM794892","serous ovarian cancer 160d","GSM794892","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 2","Stage: IIIc","surgery status: suboptimal","taxane: 1","platinum: 1","pfs (m): 16","rec (1): 1","os (m): 34","death (1): 0","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM794nnn/GSM794892/GSM794892_s160d.txt.gz","41093"
"GSM794893","serous ovarian cancer 17d","GSM794893","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 2","Stage: IIIb","surgery status: optimal","taxane: 1","platinum: 1","pfs (m): 70","rec (1): 0","os (m): 70","death (1): 0","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM794nnn/GSM794893/GSM794893_s17d.txt.gz","41093"
"GSM794894","serous ovarian cancer 171d","GSM794894","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 3","Stage: IIIc","surgery status: suboptimal","taxane: 1","platinum: 1","pfs (m): 3","rec (1): 1","os (m): 15","death (1): 1","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM794nnn/GSM794894/GSM794894_s171d.txt.gz","41093"
"GSM794895","serous ovarian cancer 173d","GSM794895","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 2","Stage: IIIc","surgery status: suboptimal","taxane: 1","platinum: 1","pfs (m): 5","rec (1): 1","os (m): 26","death (1): 1","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM794nnn/GSM794895/GSM794895_s173d.txt.gz","41093"
"GSM794896","serous ovarian cancer 174d","GSM794896","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 3","Stage: IV","surgery status: optimal","taxane: 1","platinum: 1","pfs (m): 23","rec (1): 1","os (m): 41","death (1): 1","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM794nnn/GSM794896/GSM794896_s174d.txt.gz","41093"
"GSM794897","serous ovarian cancer 178d","GSM794897","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 3","Stage: IV","surgery status: optimal","taxane: 1","platinum: 1","pfs (m): 17","rec (1): 1","os (m): 47","death (1): 1","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM794nnn/GSM794897/GSM794897_s178d.txt.gz","41093"
"GSM794898","serous ovarian cancer 18d","GSM794898","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 2","Stage: IIIc","surgery status: optimal","taxane: 1","platinum: 1","pfs (m): 74","rec (1): 0","os (m): 74","death (1): 0","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM794nnn/GSM794898/GSM794898_s18d.txt.gz","41093"
"GSM794899","serous ovarian cancer 183d","GSM794899","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 2","Stage: IIIc","surgery status: suboptimal","taxane: 1","platinum: 1","pfs (m): 72","rec (1): 0","os (m): 72","death (1): 0","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM794nnn/GSM794899/GSM794899_s183d.txt.gz","41093"
"GSM794900","serous ovarian cancer 184d","GSM794900","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 3","Stage: IIIc","surgery status: optimal","taxane: 1","platinum: 1","pfs (m): 65","rec (1): 0","os (m): 65","death (1): 0","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM794nnn/GSM794900/GSM794900_s184d.txt.gz","41093"
"GSM794901","serous ovarian cancer 185d","GSM794901","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 3","Stage: IIIc","surgery status: optimal","taxane: 1","platinum: 1","pfs (m): 20","rec (1): 1","os (m): 33","death (1): 0","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM794nnn/GSM794901/GSM794901_s185d.txt.gz","41093"
"GSM794902","serous ovarian cancer 186d","GSM794902","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 3","Stage: IIIc","surgery status: optimal","taxane: 1","platinum: 1","pfs (m): 12","rec (1): 1","os (m): 29","death (1): 0","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM794nnn/GSM794902/GSM794902_s186d.txt.gz","41093"
"GSM794903","serous ovarian cancer 2d","GSM794903","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 2","Stage: IIIc","surgery status: suboptimal","taxane: 1","platinum: 1","pfs (m): 18","rec (1): 1","os (m): 49","death (1): 1","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM794nnn/GSM794903/GSM794903_s2d.txt.gz","41093"
"GSM794904","serous ovarian cancer 20d","GSM794904","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 2","Stage: IIIc","surgery status: optimal","taxane: 1","platinum: 1","pfs (m): 102","rec (1): 0","os (m): 102","death (1): 0","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM794nnn/GSM794904/GSM794904_s20d.txt.gz","41093"
"GSM794905","serous ovarian cancer 22d","GSM794905","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 2","Stage: IIIc","surgery status: suboptimal","taxane: 1","platinum: 1","pfs (m): 15","rec (1): 0","os (m): 15","death (1): 0","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM794nnn/GSM794905/GSM794905_s22d.txt.gz","41093"
"GSM794906","serous ovarian cancer 23d","GSM794906","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 2","Stage: IIIc","surgery status: suboptimal","taxane: 1","platinum: 1","pfs (m): 2","rec (1): 1","os (m): 8","death (1): 1","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM794nnn/GSM794906/GSM794906_s23d.txt.gz","41093"
"GSM794907","serous ovarian cancer 249d","GSM794907","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 3","Stage: IIIc","surgery status: optimal","taxane: 1","platinum: 1","pfs (m): 33","rec (1): 0","os (m): 33","death (1): 0","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM794nnn/GSM794907/GSM794907_s249d.txt.gz","41093"
"GSM794908","serous ovarian cancer 25d","GSM794908","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 2","Stage: IIIb","surgery status: optimal","taxane: 1","platinum: 1","pfs (m): 29","rec (1): 1","os (m): 80","death (1): 1","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM794nnn/GSM794908/GSM794908_s25d.txt.gz","41093"
"GSM794909","serous ovarian cancer 257d","GSM794909","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 2","Stage: IIIc","surgery status: suboptimal","taxane: 1","platinum: 1","pfs (m): 36","rec (1): 1","os (m): 36","death (1): 1","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM794nnn/GSM794909/GSM794909_s257d.txt.gz","41093"
"GSM794910","serous ovarian cancer 260d","GSM794910","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 2","Stage: IIIb","surgery status: optimal","taxane: 1","platinum: 1","pfs (m): 102","rec (1): 0","os (m): 102","death (1): 0","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM794nnn/GSM794910/GSM794910_s260d.txt.gz","41093"
"GSM794911","serous ovarian cancer 262d","GSM794911","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 3","Stage: IIIc","surgery status: suboptimal","taxane: 1","platinum: 1","pfs (m): 12","rec (1): 1","os (m): 17","death (1): 1","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM794nnn/GSM794911/GSM794911_s262d.txt.gz","41093"
"GSM794912","serous ovarian cancer 264d","GSM794912","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 3","Stage: IIIc","surgery status: suboptimal","taxane: 1","platinum: 1","pfs (m): 32","rec (1): 1","os (m): 51","death (1): 1","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM794nnn/GSM794912/GSM794912_s264d.txt.gz","41093"
"GSM794913","serous ovarian cancer 266d","GSM794913","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 2","Stage: IIIc","surgery status: suboptimal","taxane: 1","platinum: 1","pfs (m): 25","rec (1): 1","os (m): 38","death (1): 0","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM794nnn/GSM794913/GSM794913_s266d.txt.gz","41093"
"GSM794914","serous ovarian cancer 267d","GSM794914","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 3","Stage: IIIc","surgery status: optimal","taxane: 1","platinum: 1","pfs (m): 34","rec (1): 1","os (m): 38","death (1): 0","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM794nnn/GSM794914/GSM794914_s267d.txt.gz","41093"
"GSM794915","serous ovarian cancer 268d","GSM794915","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 2","Stage: IIIb","surgery status: optimal","taxane: 1","platinum: 1","pfs (m): 37","rec (1): 0","os (m): 37","death (1): 0","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM794nnn/GSM794915/GSM794915_s268d.txt.gz","41093"
"GSM794916","serous ovarian cancer 269d","GSM794916","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 2","Stage: IIIc","surgery status: suboptimal","taxane: 1","platinum: 1","pfs (m): 28","rec (1): 1","os (m): 37","death (1): 0","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM794nnn/GSM794916/GSM794916_s269d.txt.gz","41093"
"GSM794917","serous ovarian cancer 27d","GSM794917","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 3","Stage: IIIc","surgery status: suboptimal","taxane: 1","platinum: 1","pfs (m): 8","rec (1): 1","os (m): 11","death (1): 1","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM794nnn/GSM794917/GSM794917_s27d.txt.gz","41093"
"GSM794918","serous ovarian cancer 299d","GSM794918","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 2","Stage: IIIc","surgery status: optimal","taxane: 1","platinum: 1","pfs (m): 8","rec (1): 1","os (m): 21","death (1): 1","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM794nnn/GSM794918/GSM794918_s299d.txt.gz","41093"
"GSM794919","serous ovarian cancer 300d","GSM794919","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 2","Stage: IV","surgery status: suboptimal","taxane: 1","platinum: 1","pfs (m): 12","rec (1): 1","os (m): 21","death (1): 0","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM794nnn/GSM794919/GSM794919_s300d.txt.gz","41093"
"GSM794920","serous ovarian cancer 301d","GSM794920","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 2","Stage: IIIb","surgery status: suboptimal","taxane: 1","platinum: 1","pfs (m): 14","rec (1): 1","os (m): 21","death (1): 0","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM794nnn/GSM794920/GSM794920_s301d.txt.gz","41093"
"GSM794921","serous ovarian cancer 302d","GSM794921","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 2","Stage: IIIc","surgery status: optimal","taxane: 1","platinum: 1","pfs (m): 18","rec (1): 0","os (m): 18","death (1): 0","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM794nnn/GSM794921/GSM794921_s302d.txt.gz","41093"
"GSM794922","serous ovarian cancer 303d","GSM794922","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 2","Stage: IIIc","surgery status: optimal","taxane: 1","platinum: 1","pfs (m): 14","rec (1): 1","os (m): 14","death (1): 0","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM794nnn/GSM794922/GSM794922_s303d.txt.gz","41093"
"GSM794923","serous ovarian cancer 304d","GSM794923","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 2","Stage: IIIc","surgery status: suboptimal","taxane: 1","platinum: 1","pfs (m): 15","rec (1): 0","os (m): 15","death (1): 0","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM794nnn/GSM794923/GSM794923_s304d.txt.gz","41093"
"GSM794924","serous ovarian cancer 305d2","GSM794924","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 2","Stage: IIIc","surgery status: optimal","taxane: 1","platinum: 1","pfs (m): 72","rec (1): 0","os (m): 72","death (1): 0","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM794nnn/GSM794924/GSM794924_s305d2.txt.gz","41093"
"GSM794925","serous ovarian cancer 306d","GSM794925","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 2","Stage: IIIc","surgery status: suboptimal","taxane: 1","platinum: 1","pfs (m): 46","rec (1): 0","os (m): 46","death (1): 0","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM794nnn/GSM794925/GSM794925_s306d.txt.gz","41093"
"GSM794926","serous ovarian cancer 307d","GSM794926","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 3","Stage: IIIc","surgery status: suboptimal","taxane: 1","platinum: 1","pfs (m): 46","rec (1): 0","os (m): 46","death (1): 0","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM794nnn/GSM794926/GSM794926_s307d.txt.gz","41093"
"GSM794927","serous ovarian cancer 310d","GSM794927","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 2","Stage: IIIb","surgery status: optimal","taxane: 1","platinum: 1","pfs (m): 6","rec (1): 0","os (m): 6","death (1): 0","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM794nnn/GSM794927/GSM794927_s310d.txt.gz","41093"
"GSM794928","serous ovarian cancer 318d","GSM794928","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 3","Stage: IIIc","surgery status: suboptimal","taxane: 1","platinum: 1","pfs (m): 9","rec (1): 1","os (m): 13","death (1): 1","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM794nnn/GSM794928/GSM794928_s318d.txt.gz","41093"
"GSM794929","serous ovarian cancer 319d","GSM794929","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 2","Stage: IIIc","surgery status: suboptimal","taxane: 1","platinum: 1","pfs (m): 12","rec (1): 1","os (m): 43","death (1): 0","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM794nnn/GSM794929/GSM794929_s319d.txt.gz","41093"
"GSM794930","serous ovarian cancer 320d2","GSM794930","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 2","Stage: IIIb","surgery status: optimal","taxane: 1","platinum: 1","pfs (m): 6","rec (1): 1","os (m): 17","death (1): 1","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM794nnn/GSM794930/GSM794930_s320d2.txt.gz","41093"
"GSM794931","serous ovarian cancer 323d","GSM794931","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 3","Stage: IIIc","surgery status: optimal","taxane: 1","platinum: 1","pfs (m): 40","rec (1): 1","os (m): 57","death (1): 0","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM794nnn/GSM794931/GSM794931_s323d.txt.gz","41093"
"GSM794932","serous ovarian cancer 327d","GSM794932","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 3","Stage: IIIc","surgery status: suboptimal","taxane: 1","platinum: 1","pfs (m): 6","rec (1): 1","os (m): 8","death (1): 1","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM794nnn/GSM794932/GSM794932_s327d.txt.gz","41093"
"GSM794933","serous ovarian cancer 330d","GSM794933","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 3","Stage: IIIc","surgery status: suboptimal","taxane: 1","platinum: 1","pfs (m): 5","rec (1): 1","os (m): 9","death (1): 1","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM794nnn/GSM794933/GSM794933_s330d.txt.gz","41093"
"GSM794934","serous ovarian cancer 331d","GSM794934","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 3","Stage: IIIc","surgery status: suboptimal","taxane: 1","platinum: 1","pfs (m): 21","rec (1): 1","os (m): 30","death (1): 0","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM794nnn/GSM794934/GSM794934_s331d.txt.gz","41093"
"GSM794935","serous ovarian cancer 333d2","GSM794935","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 2","Stage: IIIc","surgery status: optimal","taxane: 1","platinum: 1","pfs (m): 29","rec (1): 0","os (m): 29","death (1): 0","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM794nnn/GSM794935/GSM794935_s333d2.txt.gz","41093"
"GSM794936","serous ovarian cancer 335d","GSM794936","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 3","Stage: IIIc","surgery status: optimal","taxane: 1","platinum: 1","pfs (m): 12","rec (1): 1","os (m): 16","death (1): 1","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM794nnn/GSM794936/GSM794936_s335d.txt.gz","41093"
"GSM794937","serous ovarian cancer 337d","GSM794937","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 3","Stage: IV","surgery status: suboptimal","taxane: 1","platinum: 1","pfs (m): 13","rec (1): 1","os (m): 40","death (1): 0","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM794nnn/GSM794937/GSM794937_s337d.txt.gz","41093"
"GSM794938","serous ovarian cancer 340d","GSM794938","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 2","Stage: IIIc","surgery status: suboptimal","taxane: 1","platinum: 1","pfs (m): 2","rec (1): 1","os (m): 2","death (1): 1","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM794nnn/GSM794938/GSM794938_s340d.txt.gz","41093"
"GSM794939","serous ovarian cancer 342d","GSM794939","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 3","Stage: IIIc","surgery status: optimal","taxane: 1","platinum: 1","pfs (m): 44","rec (1): 0","os (m): 44","death (1): 0","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM794nnn/GSM794939/GSM794939_s342d.txt.gz","41093"
"GSM794940","serous ovarian cancer 346d","GSM794940","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 3","Stage: IIIc","surgery status: optimal","taxane: 1","platinum: 1","pfs (m): 23","rec (1): 1","os (m): 36","death (1): 0","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM794nnn/GSM794940/GSM794940_s346d.txt.gz","41093"
"GSM794941","serous ovarian cancer 347d","GSM794941","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 3","Stage: IIIc","surgery status: suboptimal","taxane: 1","platinum: 1","pfs (m): 18","rec (1): 1","os (m): 48","death (1): 0","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM794nnn/GSM794941/GSM794941_s347d.txt.gz","41093"
"GSM794942","serous ovarian cancer 348d2","GSM794942","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 3","Stage: IIIc","surgery status: optimal","taxane: 1","platinum: 1","pfs (m): 24","rec (1): 1","os (m): 50","death (1): 0","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM794nnn/GSM794942/GSM794942_s348d2.txt.gz","41093"
"GSM794943","serous ovarian cancer 350d","GSM794943","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 3","Stage: IIIc","surgery status: suboptimal","taxane: 1","platinum: 1","pfs (m): 2","rec (1): 1","os (m): 24","death (1): 1","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM794nnn/GSM794943/GSM794943_s350d.txt.gz","41093"
"GSM794944","serous ovarian cancer 352d","GSM794944","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 2","Stage: IIIc","surgery status: suboptimal","taxane: 1","platinum: 1","pfs (m): 18","rec (1): 1","os (m): 36","death (1): 1","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM794nnn/GSM794944/GSM794944_s352d.txt.gz","41093"
"GSM794945","serous ovarian cancer 353d","GSM794945","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 3","Stage: IV","surgery status: optimal","taxane: 1","platinum: 1","pfs (m): 22","rec (1): 1","os (m): 36","death (1): 1","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM794nnn/GSM794945/GSM794945_s353d.txt.gz","41093"
"GSM794946","serous ovarian cancer 355d","GSM794946","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 2","Stage: IIIc","surgery status: optimal","taxane: 1","platinum: 1","pfs (m): 23","rec (1): 1","os (m): 41","death (1): 1","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM794nnn/GSM794946/GSM794946_s355d.txt.gz","41093"
"GSM794947","serous ovarian cancer 356d","GSM794947","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 2","Stage: IV","surgery status: optimal","taxane: 1","platinum: 1","pfs (m): 58","rec (1): 0","os (m): 58","death (1): 0","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM794nnn/GSM794947/GSM794947_s356d.txt.gz","41093"
"GSM794948","serous ovarian cancer 357d","GSM794948","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 3","Stage: IIIc","surgery status: suboptimal","taxane: 1","platinum: 1","pfs (m): 22","rec (1): 1","os (m): 50","death (1): 1","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM794nnn/GSM794948/GSM794948_s357d.txt.gz","41093"
"GSM794949","serous ovarian cancer 358d","GSM794949","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 2","Stage: IIIc","surgery status: optimal","taxane: 1","platinum: 1","pfs (m): 27","rec (1): 1","os (m): 52","death (1): 0","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM794nnn/GSM794949/GSM794949_s358d.txt.gz","41093"
"GSM794950","serous ovarian cancer 36d","GSM794950","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 2","Stage: IV","surgery status: optimal","taxane: 1","platinum: 1","pfs (m): 23","rec (1): 1","os (m): 28","death (1): 1","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM794nnn/GSM794950/GSM794950_s36d.txt.gz","41093"
"GSM794951","serous ovarian cancer 360d","GSM794951","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 2","Stage: IIIc","surgery status: suboptimal","taxane: 1","platinum: 1","pfs (m): 32","rec (1): 1","os (m): 62","death (1): 0","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM794nnn/GSM794951/GSM794951_s360d.txt.gz","41093"
"GSM794952","serous ovarian cancer 362d","GSM794952","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 2","Stage: IIIc","surgery status: suboptimal","taxane: 1","platinum: 1","pfs (m): 14","rec (1): 1","os (m): 25","death (1): 1","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM794nnn/GSM794952/GSM794952_s362d.txt.gz","41093"
"GSM794953","serous ovarian cancer 363d","GSM794953","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 2","Stage: IIIc","surgery status: optimal","taxane: 1","platinum: 1","pfs (m): 72","rec (1): 0","os (m): 72","death (1): 0","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM794nnn/GSM794953/GSM794953_s363d.txt.gz","41093"
"GSM794954","serous ovarian cancer 365d","GSM794954","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 3","Stage: IIIc","surgery status: optimal","taxane: 1","platinum: 1","pfs (m): 32","rec (1): 1","os (m): 37","death (1): 1","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM794nnn/GSM794954/GSM794954_s365d.txt.gz","41093"
"GSM794955","serous ovarian cancer 366d","GSM794955","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 2","Stage: IV","surgery status: suboptimal","taxane: 1","platinum: 1","pfs (m): 13","rec (1): 1","os (m): 18","death (1): 1","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM794nnn/GSM794955/GSM794955_s366d.txt.gz","41093"
"GSM794956","serous ovarian cancer 367d","GSM794956","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 3","Stage: IIIc","surgery status: optimal","taxane: 1","platinum: 1","pfs (m): 19","rec (1): 1","os (m): 49","death (1): 1","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM794nnn/GSM794956/GSM794956_s367d.txt.gz","41093"
"GSM794957","serous ovarian cancer 368d2","GSM794957","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 3","Stage: IV","surgery status: suboptimal","taxane: 1","platinum: 1","pfs (m): 8","rec (1): 1","os (m): 32","death (1): 1","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM794nnn/GSM794957/GSM794957_s368d2.txt.gz","41093"
"GSM794958","serous ovarian cancer 38d","GSM794958","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 2","Stage: IIIb","surgery status: optimal","taxane: 1","platinum: 1","pfs (m): 15","rec (1): 1","os (m): 64","death (1): 1","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM794nnn/GSM794958/GSM794958_s38d.txt.gz","41093"
"GSM794959","serous ovarian cancer 4d","GSM794959","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 3","Stage: IIIc","surgery status: suboptimal","taxane: 1","platinum: 1","pfs (m): 2","rec (1): 1","os (m): 41","death (1): 1","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM794nnn/GSM794959/GSM794959_s4d.txt.gz","41093"
"GSM794960","serous ovarian cancer 41d2R","GSM794960","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 2","Stage: IIIb","surgery status: optimal","taxane: 1","platinum: 1","pfs (m): 99","rec (1): 1","os (m): 104","death (1): 0","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM794nnn/GSM794960/GSM794960_s41d2R.txt.gz","41093"
"GSM794961","serous ovarian cancer 42d","GSM794961","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 3","Stage: IIIc","surgery status: suboptimal","taxane: 1","platinum: 1","pfs (m): 17","rec (1): 1","os (m): 60","death (1): 1","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM794nnn/GSM794961/GSM794961_s42d.txt.gz","41093"
"GSM794962","serous ovarian cancer 43d","GSM794962","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 3","Stage: IIIc","surgery status: suboptimal","taxane: 1","platinum: 1","pfs (m): 7","rec (1): 1","os (m): 34","death (1): 1","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM794nnn/GSM794962/GSM794962_s43d.txt.gz","41093"
"GSM794963","serous ovarian cancer 44d","GSM794963","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 3","Stage: IIIc","surgery status: suboptimal","taxane: 1","platinum: 1","pfs (m): 9","rec (1): 1","os (m): 17","death (1): 1","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM794nnn/GSM794963/GSM794963_s44d.txt.gz","41093"
"GSM794964","serous ovarian cancer 45d","GSM794964","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 2","Stage: IIIc","surgery status: optimal","taxane: 1","platinum: 1","pfs (m): 35","rec (1): 1","os (m): 71","death (1): 0","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM794nnn/GSM794964/GSM794964_s45d.txt.gz","41093"
"GSM794965","serous ovarian cancer 456d","GSM794965","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 2","Stage: IIIc","surgery status: optimal","taxane: 1","platinum: 1","pfs (m): 28","rec (1): 0","os (m): 28","death (1): 0","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM794nnn/GSM794965/GSM794965_s456d.txt.gz","41093"
"GSM794966","serous ovarian cancer 461d","GSM794966","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 2","Stage: IV","surgery status: suboptimal","taxane: 1","platinum: 1","pfs (m): 2","rec (1): 1","os (m): 2","death (1): 1","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM794nnn/GSM794966/GSM794966_s461d.txt.gz","41093"
"GSM794967","serous ovarian cancer 462d","GSM794967","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 2","Stage: IIIc","surgery status: suboptimal","taxane: 1","platinum: 1","pfs (m): 20","rec (1): 1","os (m): 20","death (1): 0","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM794nnn/GSM794967/GSM794967_s462d.txt.gz","41093"
"GSM794968","serous ovarian cancer 464d","GSM794968","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 2","Stage: IIIc","surgery status: Optimal","taxane: 1","platinum: 1","pfs (m): 57","rec (1): 0","os (m): 57","death (1): 0","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM794nnn/GSM794968/GSM794968_s464d.txt.gz","41093"
"GSM794969","serous ovarian cancer 467d","GSM794969","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 3","Stage: IIIc","surgery status: suboptimal","taxane: 1","platinum: 1","pfs (m): 22","rec (1): 1","os (m): 57","death (1): 0","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM794nnn/GSM794969/GSM794969_s467d.txt.gz","41093"
"GSM794970","serous ovarian cancer 468d","GSM794970","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 2","Stage: IIIc","surgery status: suboptimal","taxane: 1","platinum: 1","pfs (m): 15","rec (1): 1","os (m): 22","death (1): 1","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM794nnn/GSM794970/GSM794970_s468d.txt.gz","41093"
"GSM794971","serous ovarian cancer 469d","GSM794971","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 2","Stage: IV","surgery status: suboptimal","taxane: 1","platinum: 1","pfs (m): 2","rec (1): 1","os (m): 2","death (1): 1","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM794nnn/GSM794971/GSM794971_s469d.txt.gz","41093"
"GSM794972","serous ovarian cancer 470d2","GSM794972","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 3","Stage: IIIc","surgery status: optimal","taxane: 1","platinum: 1","pfs (m): 23","rec (1): 1","os (m): 87","death (1): 0","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM794nnn/GSM794972/GSM794972_s470d2.txt.gz","41093"
"GSM794973","serous ovarian cancer 475d2","GSM794973","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 3","Stage: IV","surgery status: suboptimal","taxane: 1","platinum: 1","pfs (m): 8","rec (1): 1","os (m): 21","death (1): 1","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM794nnn/GSM794973/GSM794973_s475d2.txt.gz","41093"
"GSM794974","serous ovarian cancer 476d","GSM794974","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 3","Stage: IIIc","surgery status: suboptimal","taxane: 1","platinum: 1","pfs (m): 14","rec (1): 1","os (m): 17","death (1): 1","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM794nnn/GSM794974/GSM794974_s476d.txt.gz","41093"
"GSM794975","serous ovarian cancer 477d","GSM794975","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 2","Stage: IIIc","surgery status: suboptimal","taxane: 1","platinum: 1","pfs (m): 70","rec (1): 1","os (m): 82","death (1): 0","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM794nnn/GSM794975/GSM794975_s477d.txt.gz","41093"
"GSM794976","serous ovarian cancer 479d","GSM794976","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 2","Stage: IV","surgery status: suboptimal","taxane: 1","platinum: 1","pfs (m): 19","rec (1): 1","os (m): 40","death (1): 1","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM794nnn/GSM794976/GSM794976_s479d.txt.gz","41093"
"GSM794977","serous ovarian cancer 480d2","GSM794977","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 2","Stage: IIIc","surgery status: suboptimal","taxane: 1","platinum: 1","pfs (m): 5","rec (1): 1","os (m): 11","death (1): 1","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM794nnn/GSM794977/GSM794977_s480d2.txt.gz","41093"
"GSM794978","serous ovarian cancer 481d","GSM794978","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 2","Stage: IIIc","surgery status: suboptimal","taxane: 1","platinum: 1","pfs (m): 67","rec (1): 0","os (m): 67","death (1): 0","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM794nnn/GSM794978/GSM794978_s481d.txt.gz","41093"
"GSM794979","serous ovarian cancer 482d","GSM794979","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 2","Stage: IIIc","surgery status: suboptimal","taxane: 1","platinum: 1","pfs (m): 12","rec (1): 1","os (m): 45","death (1): 1","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM794nnn/GSM794979/GSM794979_s482d.txt.gz","41093"
"GSM794980","serous ovarian cancer 483d","GSM794980","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 3","Stage: IIIc","surgery status: suboptimal","taxane: 1","platinum: 1","pfs (m): 19","rec (1): 1","os (m): 62","death (1): 0","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM794nnn/GSM794980/GSM794980_s483d.txt.gz","41093"
"GSM794981","serous ovarian cancer 484d","GSM794981","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 3","Stage: IV","surgery status: suboptimal","taxane: 1","platinum: 1","pfs (m): 15","rec (1): 1","os (m): 57","death (1): 0","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM794nnn/GSM794981/GSM794981_s484d.txt.gz","41093"
"GSM794982","serous ovarian cancer 486d","GSM794982","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 2","Stage: IIIc","surgery status: suboptimal","taxane: 1","platinum: 1","pfs (m): 2","rec (1): 1","os (m): 16","death (1): 1","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM794nnn/GSM794982/GSM794982_s486d.txt.gz","41093"
"GSM794983","serous ovarian cancer 487d","GSM794983","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 3","Stage: IIIc","surgery status: suboptimal","taxane: 1","platinum: 1","pfs (m): 56","rec (1): 0","os (m): 56","death (1): 0","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM794nnn/GSM794983/GSM794983_s487d.txt.gz","41093"
"GSM794984","serous ovarian cancer 488d","GSM794984","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 3","Stage: IV","surgery status: suboptimal","taxane: 1","platinum: 1","pfs (m): 56","rec (1): 0","os (m): 56","death (1): 0","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM794nnn/GSM794984/GSM794984_s488d.txt.gz","41093"
"GSM794985","serous ovarian cancer 49d","GSM794985","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 3","Stage: IIIc","surgery status: suboptimal","taxane: 1","platinum: 1","pfs (m): 62","rec (1): 0","os (m): 62","death (1): 0","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM794nnn/GSM794985/GSM794985_s49d.txt.gz","41093"
"GSM794986","serous ovarian cancer 490d","GSM794986","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 2","Stage: IIIc","surgery status: suboptimal","taxane: 1","platinum: 1","pfs (m): 15","rec (1): 1","os (m): 49","death (1): 0","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM794nnn/GSM794986/GSM794986_s490d.txt.gz","41093"
"GSM794987","serous ovarian cancer 491d","GSM794987","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 3","Stage: IIIc","surgery status: suboptimal","taxane: 1","platinum: 1","pfs (m): 45","rec (1): 0","os (m): 45","death (1): 0","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM794nnn/GSM794987/GSM794987_s491d.txt.gz","41093"
"GSM794988","serous ovarian cancer 493d","GSM794988","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 2","Stage: IIIc","surgery status: suboptimal","taxane: 1","platinum: 1","pfs (m): 5","rec (1): 1","os (m): 35","death (1): 1","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM794nnn/GSM794988/GSM794988_s493d.txt.gz","41093"
"GSM794989","serous ovarian cancer 494d","GSM794989","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 3","Stage: IIIc","surgery status: suboptimal","taxane: 1","platinum: 1","pfs (m): 6","rec (1): 1","os (m): 15","death (1): 1","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM794nnn/GSM794989/GSM794989_s494d.txt.gz","41093"
"GSM794990","serous ovarian cancer 495d","GSM794990","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 3","Stage: IIIc","surgery status: optimal","taxane: 1","platinum: 1","pfs (m): 15","rec (1): 1","os (m): 51","death (1): 1","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM794nnn/GSM794990/GSM794990_s495d.txt.gz","41093"
"GSM794991","serous ovarian cancer 496d","GSM794991","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 3","Stage: IIIc","surgery status: suboptimal","taxane: 1","platinum: 1","pfs (m): 5","rec (1): 1","os (m): 24","death (1): 1","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM794nnn/GSM794991/GSM794991_s496d.txt.gz","41093"
"GSM794992","serous ovarian cancer 497d","GSM794992","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 3","Stage: IIIc","surgery status: suboptimal","taxane: 1","platinum: 1","pfs (m): 8","rec (1): 1","os (m): 22","death (1): 1","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM794nnn/GSM794992/GSM794992_s497d.txt.gz","41093"
"GSM794993","serous ovarian cancer 498d2","GSM794993","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 2","Stage: IIIc","surgery status: suboptimal","taxane: 1","platinum: 1","pfs (m): 18","rec (1): 1","os (m): 39","death (1): 1","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM794nnn/GSM794993/GSM794993_s498d2.txt.gz","41093"
"GSM794994","serous ovarian cancer 499d","GSM794994","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 2","Stage: IIIc","surgery status: suboptimal","taxane: 1","platinum: 1","pfs (m): 7","rec (1): 1","os (m): 39","death (1): 1","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM794nnn/GSM794994/GSM794994_s499d.txt.gz","41093"
"GSM794995","serous ovarian cancer 500d","GSM794995","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 2","Stage: IIIc","surgery status: suboptimal","taxane: 1","platinum: 1","pfs (m): 9","rec (1): 1","os (m): 38","death (1): 1","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM794nnn/GSM794995/GSM794995_s500d.txt.gz","41093"
"GSM794996","serous ovarian cancer 501d","GSM794996","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 3","Stage: IIIc","surgery status: suboptimal","taxane: 1","platinum: 1","pfs (m): 15","rec (1): 1","os (m): 42","death (1): 1","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM794nnn/GSM794996/GSM794996_s501d.txt.gz","41093"
"GSM794997","serous ovarian cancer 502d2","GSM794997","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 2","Stage: IIIc","surgery status: suboptimal","taxane: 1","platinum: 1","pfs (m): 52","rec (1): 0","os (m): 52","death (1): 0","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM794nnn/GSM794997/GSM794997_s502d2.txt.gz","41093"
"GSM794998","serous ovarian cancer 503d","GSM794998","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 3","Stage: IIIc","surgery status: suboptimal","taxane: 1","platinum: 1","pfs (m): 32","rec (1): 1","os (m): 32","death (1): 0","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM794nnn/GSM794998/GSM794998_s503d.txt.gz","41093"
"GSM794999","serous ovarian cancer 504d2","GSM794999","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 3","Stage: IV","surgery status: suboptimal","taxane: 1","platinum: 1","pfs (m): 6","rec (1): 1","os (m): 13","death (1): 1","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM794nnn/GSM794999/GSM794999_s504d2.txt.gz","41093"
"GSM795000","serous ovarian cancer 505d","GSM795000","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 2","Stage: IIIc","surgery status: optimal","taxane: 1","platinum: 1","pfs (m): 52","rec (1): 0","os (m): 52","death (1): 0","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM795nnn/GSM795000/GSM795000_s505d.txt.gz","41093"
"GSM795001","serous ovarian cancer 507d2","GSM795001","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 3","Stage: IV","surgery status: optimal","taxane: 1","platinum: 1","pfs (m): 6","rec (1): 1","os (m): 113","death (1): 1","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM795nnn/GSM795001/GSM795001_s507d2.txt.gz","41093"
"GSM795002","serous ovarian cancer 508d2","GSM795002","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 3","Stage: IV","surgery status: optimal","taxane: 1","platinum: 1","pfs (m): 37","rec (1): 0","os (m): 37","death (1): 0","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM795nnn/GSM795002/GSM795002_s508d2.txt.gz","41093"
"GSM795003","serous ovarian cancer 509d","GSM795003","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 2","Stage: IIIc","surgery status: optimal","taxane: 1","platinum: 1","pfs (m): 7","rec (1): 1","os (m): 45","death (1): 1","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM795nnn/GSM795003/GSM795003_s509d.txt.gz","41093"
"GSM795004","serous ovarian cancer 51d","GSM795004","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 3","Stage: IIIc","surgery status: suboptimal","taxane: 1","platinum: 1","pfs (m): 14","rec (1): 1","os (m): 48","death (1): 0","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM795nnn/GSM795004/GSM795004_s51d.txt.gz","41093"
"GSM795005","serous ovarian cancer 510d2","GSM795005","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 3","Stage: IIIc","surgery status: suboptimal","taxane: 1","platinum: 1","pfs (m): 10","rec (1): 1","os (m): 26","death (1): 1","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM795nnn/GSM795005/GSM795005_s510d2.txt.gz","41093"
"GSM795006","serous ovarian cancer 511d","GSM795006","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 3","Stage: IIIc","surgery status: suboptimal","taxane: 1","platinum: 1","pfs (m): 5","rec (1): 1","os (m): 25","death (1): 1","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM795nnn/GSM795006/GSM795006_s511d.txt.gz","41093"
"GSM795007","serous ovarian cancer 512d","GSM795007","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 2","Stage: IIIc","surgery status: suboptimal","taxane: 1","platinum: 1","pfs (m): 84","rec (1): 1","os (m): 128","death (1): 0","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM795nnn/GSM795007/GSM795007_s512d.txt.gz","41093"
"GSM795008","serous ovarian cancer 513d","GSM795008","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 3","Stage: IIIc","surgery status: suboptimal","taxane: 1","platinum: 1","pfs (m): 10","rec (1): 1","os (m): 28","death (1): 1","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM795nnn/GSM795008/GSM795008_s513d.txt.gz","41093"
"GSM795009","serous ovarian cancer 514d2","GSM795009","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 3","Stage: IIIc","surgery status: suboptimal","taxane: 1","platinum: 1","pfs (m): 6","rec (1): 1","os (m): 36","death (1): 1","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM795nnn/GSM795009/GSM795009_s514d2.txt.gz","41093"
"GSM795010","serous ovarian cancer 516d","GSM795010","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 3","Stage: IV","surgery status: optimal","taxane: 1","platinum: 1","pfs (m): 24","rec (1): 1","os (m): 120","death (1): 1","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM795nnn/GSM795010/GSM795010_s516d.txt.gz","41093"
"GSM795011","serous ovarian cancer 518d","GSM795011","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 3","Stage: IIIc","surgery status: optimal","taxane: 1","platinum: 1","pfs (m): 25","rec (1): 1","os (m): 54","death (1): 1","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM795nnn/GSM795011/GSM795011_s518d.txt.gz","41093"
"GSM795012","serous ovarian cancer 519d2","GSM795012","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 3","Stage: IIIc","surgery status: suboptimal","taxane: 1","platinum: 1","pfs (m): 7","rec (1): 1","os (m): 12","death (1): 1","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM795nnn/GSM795012/GSM795012_s519d2.txt.gz","41093"
"GSM795013","serous ovarian cancer 520d2","GSM795013","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 3","Stage: IV","surgery status: suboptimal","taxane: 1","platinum: 1","pfs (m): 36","rec (1): 0","os (m): 36","death (1): 0","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM795nnn/GSM795013/GSM795013_s520d2.txt.gz","41093"
"GSM795014","serous ovarian cancer 521d2","GSM795014","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 2","Stage: IIIc","surgery status: suboptimal","taxane: 1","platinum: 1","pfs (m): 6","rec (1): 1","os (m): 26","death (1): 1","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM795nnn/GSM795014/GSM795014_s521d2.txt.gz","41093"
"GSM795015","serous ovarian cancer 522d2","GSM795015","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 3","Stage: IIIc","surgery status: suboptimal","taxane: 1","platinum: 1","pfs (m): 11","rec (1): 1","os (m): 123","death (1): 0","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM795nnn/GSM795015/GSM795015_s522d2.txt.gz","41093"
"GSM795016","serous ovarian cancer 523d2","GSM795016","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 2","Stage: IV","surgery status: optimal","taxane: 1","platinum: 1","pfs (m): 6","rec (1): 1","os (m): 58","death (1): 1","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM795nnn/GSM795016/GSM795016_s523d2.txt.gz","41093"
"GSM795017","serous ovarian cancer 525d2","GSM795017","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 2","Stage: IIIc","surgery status: suboptimal","taxane: 1","platinum: 1","pfs (m): 7","rec (1): 1","os (m): 48","death (1): 1","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM795nnn/GSM795017/GSM795017_s525d2.txt.gz","41093"
"GSM795018","serous ovarian cancer 526d2","GSM795018","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 3","Stage: IIIc","surgery status: optimal","taxane: 1","platinum: 1","pfs (m): 19","rec (1): 1","os (m): 121","death (1): 0","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM795nnn/GSM795018/GSM795018_s526d2.txt.gz","41093"
"GSM795019","serous ovarian cancer 527d2","GSM795019","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 3","Stage: IV","surgery status: suboptimal","taxane: 1","platinum: 1","pfs (m): 27","rec (1): 1","os (m): 105","death (1): 1","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM795nnn/GSM795019/GSM795019_s527d2.txt.gz","41093"
"GSM795020","serous ovarian cancer 528d2","GSM795020","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 3","Stage: IIIc","surgery status: optimal","taxane: 1","platinum: 1","pfs (m): 113","rec (1): 0","os (m): 113","death (1): 0","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM795nnn/GSM795020/GSM795020_s528d2.txt.gz","41093"
"GSM795021","serous ovarian cancer 529d","GSM795021","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 2","Stage: IIIc","surgery status: optimal","taxane: 1","platinum: 1","pfs (m): 25","rec (1): 1","os (m): 112","death (1): 0","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM795nnn/GSM795021/GSM795021_s529d.txt.gz","41093"
"GSM795022","serous ovarian cancer 53d","GSM795022","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 3","Stage: IV","surgery status: suboptimal","taxane: 1","platinum: 1","pfs (m): 9","rec (1): 1","os (m): 24","death (1): 1","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM795nnn/GSM795022/GSM795022_s53d.txt.gz","41093"
"GSM795023","serous ovarian cancer 531d2","GSM795023","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 3","Stage: IV","surgery status: suboptimal","taxane: 1","platinum: 1","pfs (m): 78","rec (1): 0","os (m): 78","death (1): 0","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM795nnn/GSM795023/GSM795023_s531d2.txt.gz","41093"
"GSM795024","serous ovarian cancer 533d","GSM795024","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 2","Stage: IIIc","surgery status: optimal","taxane: 1","platinum: 1","pfs (m): 7","rec (1): 1","os (m): 39","death (1): 1","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM795nnn/GSM795024/GSM795024_s533d.txt.gz","41093"
"GSM795025","serous ovarian cancer 534d","GSM795025","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 2","Stage: IIIc","surgery status: optimal","taxane: 1","platinum: 1","pfs (m): 7","rec (1): 1","os (m): 12","death (1): 1","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM795nnn/GSM795025/GSM795025_s534d.txt.gz","41093"
"GSM795026","serous ovarian cancer 535d","GSM795026","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 3","Stage: IIIa","surgery status: optimal","taxane: 1","platinum: 1","pfs (m): 64","rec (1): 1","os (m): 64","death (1): 0","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM795nnn/GSM795026/GSM795026_s535d.txt.gz","41093"
"GSM795027","serous ovarian cancer 536d","GSM795027","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 3","Stage: IIIc","surgery status: optimal","taxane: 1","platinum: 1","pfs (m): 77","rec (1): 0","os (m): 77","death (1): 0","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM795nnn/GSM795027/GSM795027_s536d.txt.gz","41093"
"GSM795028","serous ovarian cancer 537d2","GSM795028","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 2","Stage: IIIc","surgery status: suboptimal","taxane: 1","platinum: 1","pfs (m): 24","rec (1): 1","os (m): 55","death (1): 0","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM795nnn/GSM795028/GSM795028_s537d2.txt.gz","41093"
"GSM795029","serous ovarian cancer 538d","GSM795029","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 3","Stage: IV","surgery status: optimal","taxane: 1","platinum: 1","pfs (m): 13","rec (1): 1","os (m): 40","death (1): 1","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM795nnn/GSM795029/GSM795029_s538d.txt.gz","41093"
"GSM795030","serous ovarian cancer 539d","GSM795030","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 3","Stage: IV","surgery status: suboptimal","taxane: 1","platinum: 1","pfs (m): 5","rec (1): 1","os (m): 23","death (1): 1","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM795nnn/GSM795030/GSM795030_s539d.txt.gz","41093"
"GSM795031","serous ovarian cancer 54d","GSM795031","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 2","Stage: IIIb","surgery status: optimal","taxane: 1","platinum: 1","pfs (m): 54","rec (1): 0","os (m): 54","death (1): 0","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM795nnn/GSM795031/GSM795031_s54d.txt.gz","41093"
"GSM795032","serous ovarian cancer 541d","GSM795032","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 3","Stage: IV","surgery status: suboptimal","taxane: 1","platinum: 1","pfs (m): 3","rec (1): 1","os (m): 33","death (1): 1","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM795nnn/GSM795032/GSM795032_s541d.txt.gz","41093"
"GSM795033","serous ovarian cancer 542d","GSM795033","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 3","Stage: IV","surgery status: suboptimal","taxane: 1","platinum: 1","pfs (m): 4","rec (1): 1","os (m): 23","death (1): 1","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM795nnn/GSM795033/GSM795033_s542d.txt.gz","41093"
"GSM795034","serous ovarian cancer 543d","GSM795034","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 2","Stage: IIIc","surgery status: suboptimal","taxane: 1","platinum: 1","pfs (m): 51","rec (1): 0","os (m): 51","death (1): 0","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM795nnn/GSM795034/GSM795034_s543d.txt.gz","41093"
"GSM795035","serous ovarian cancer 544d","GSM795035","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 3","Stage: IV","surgery status: suboptimal","taxane: 1","platinum: 1","pfs (m): 61","rec (1): 0","os (m): 61","death (1): 0","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM795nnn/GSM795035/GSM795035_s544d.txt.gz","41093"
"GSM795036","serous ovarian cancer 546d","GSM795036","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 3","Stage: IIIc","surgery status: suboptimal","taxane: 1","platinum: 1","pfs (m): 63","rec (1): 0","os (m): 63","death (1): 0","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM795nnn/GSM795036/GSM795036_s546d.txt.gz","41093"
"GSM795037","serous ovarian cancer 547d","GSM795037","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 2","Stage: IIIc","surgery status: suboptimal","taxane: 1","platinum: 1","pfs (m): 5","rec (1): 1","os (m): 27","death (1): 1","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM795nnn/GSM795037/GSM795037_s547d.txt.gz","41093"
"GSM795038","serous ovarian cancer 548d","GSM795038","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 2","Stage: IV","surgery status: suboptimal","taxane: 1","platinum: 1","pfs (m): 17","rec (1): 1","os (m): 42","death (1): 1","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM795nnn/GSM795038/GSM795038_s548d.txt.gz","41093"
"GSM795039","serous ovarian cancer 549d2","GSM795039","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 3","Stage: IIIc","surgery status: suboptimal","taxane: 1","platinum: 1","pfs (m): 85","rec (1): 0","os (m): 85","death (1): 0","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM795nnn/GSM795039/GSM795039_s549d2.txt.gz","41093"
"GSM795040","serous ovarian cancer 55d","GSM795040","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 3","Stage: IIIc","surgery status: optimal","taxane: 1","platinum: 1","pfs (m): 55","rec (1): 0","os (m): 55","death (1): 0","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM795nnn/GSM795040/GSM795040_s55d.txt.gz","41093"
"GSM795041","serous ovarian cancer 551d2","GSM795041","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 3","Stage: IIIc","surgery status: suboptimal","taxane: 1","platinum: 1","pfs (m): 60","rec (1): 0","os (m): 60","death (1): 0","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM795nnn/GSM795041/GSM795041_s551d2.txt.gz","41093"
"GSM795042","serous ovarian cancer 552d2","GSM795042","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 2","Stage: IIIc","surgery status: suboptimal","taxane: 1","platinum: 1","pfs (m): 9","rec (1): 1","os (m): 25","death (1): 1","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM795nnn/GSM795042/GSM795042_s552d2.txt.gz","41093"
"GSM795043","serous ovarian cancer 553d2","GSM795043","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 2","Stage: IIIb","surgery status: optimal","taxane: 1","platinum: 1","pfs (m): 4","rec (1): 1","os (m): 15","death (1): 1","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM795nnn/GSM795043/GSM795043_s553d2.txt.gz","41093"
"GSM795044","serous ovarian cancer 554d2","GSM795044","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 3","Stage: IIIc","surgery status: suboptimal","taxane: 1","platinum: 1","pfs (m): 21","rec (1): 1","os (m): 30","death (1): 1","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM795nnn/GSM795044/GSM795044_s554d2.txt.gz","41093"
"GSM795045","serous ovarian cancer 555d2","GSM795045","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 3","Stage: IV","surgery status: optimal","taxane: 1","platinum: 1","pfs (m): 17","rec (1): 1","os (m): 32","death (1): 1","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM795nnn/GSM795045/GSM795045_s555d2.txt.gz","41093"
"GSM795046","serous ovarian cancer 556d2","GSM795046","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 3","Stage: IIIc","surgery status: suboptimal","taxane: 1","platinum: 1","pfs (m): 61","rec (1): 0","os (m): 61","death (1): 0","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM795nnn/GSM795046/GSM795046_s556d2.txt.gz","41093"
"GSM795047","serous ovarian cancer 557d2","GSM795047","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 2","Stage: IIIc","surgery status: optimal","taxane: 1","platinum: 1","pfs (m): 60","rec (1): 0","os (m): 60","death (1): 0","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM795nnn/GSM795047/GSM795047_s557d2.txt.gz","41093"
"GSM795048","serous ovarian cancer 558d2","GSM795048","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 2","Stage: IV","surgery status: optimal","taxane: 1","platinum: 1","pfs (m): 25","rec (1): 1","os (m): 78","death (1): 0","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM795nnn/GSM795048/GSM795048_s558d2.txt.gz","41093"
"GSM795049","serous ovarian cancer 559d2","GSM795049","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 3","Stage: IIIc","surgery status: suboptimal","taxane: 1","platinum: 1","pfs (m): 61","rec (1): 0","os (m): 61","death (1): 0","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM795nnn/GSM795049/GSM795049_s559d2.txt.gz","41093"
"GSM795050","serous ovarian cancer 56d","GSM795050","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 3","Stage: IIIc","surgery status: suboptimal","taxane: 1","platinum: 1","pfs (m): 14","rec (1): 1","os (m): 39","death (1): 1","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM795nnn/GSM795050/GSM795050_s56d.txt.gz","41093"
"GSM795051","serous ovarian cancer 560d2","GSM795051","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 3","Stage: IV","surgery status: optimal","taxane: 1","platinum: 1","pfs (m): 12","rec (1): 1","os (m): 25","death (1): 1","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM795nnn/GSM795051/GSM795051_s560d2.txt.gz","41093"
"GSM795052","serous ovarian cancer 561d2","GSM795052","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 3","Stage: IIIc","surgery status: optimal","taxane: 1","platinum: 1","pfs (m): 72","rec (1): 0","os (m): 72","death (1): 0","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM795nnn/GSM795052/GSM795052_s561d2.txt.gz","41093"
"GSM795053","serous ovarian cancer 564d","GSM795053","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 2","Stage: IV","surgery status: optimal","taxane: 1","platinum: 1","pfs (m): 11","rec (1): 1","os (m): 31","death (1): 1","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM795nnn/GSM795053/GSM795053_s564d.txt.gz","41093"
"GSM795054","serous ovarian cancer 565d2","GSM795054","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 3","Stage: IV","surgery status: suboptimal","taxane: 1","platinum: 1","pfs (m): 48","rec (1): 0","os (m): 48","death (1): 0","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM795nnn/GSM795054/GSM795054_s565d2.txt.gz","41093"
"GSM795055","serous ovarian cancer 566d2","GSM795055","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 3","Stage: IV","surgery status: suboptimal","taxane: 1","platinum: 1","pfs (m): 22","rec (1): 1","os (m): 59","death (1): 0","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM795nnn/GSM795055/GSM795055_s566d2.txt.gz","41093"
"GSM795056","serous ovarian cancer 567d2","GSM795056","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 3","Stage: IIIc","surgery status: optimal","taxane: 1","platinum: 1","pfs (m): 14","rec (1): 1","os (m): 57","death (1): 0","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM795nnn/GSM795056/GSM795056_s567d2.txt.gz","41093"
"GSM795057","serous ovarian cancer 569d","GSM795057","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 2","Stage: IIIc","surgery status: suboptimal","taxane: 1","platinum: 1","pfs (m): 14","rec (1): 1","os (m): 20","death (1): 1","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM795nnn/GSM795057/GSM795057_s569d.txt.gz","41093"
"GSM795058","serous ovarian cancer 57d","GSM795058","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 3","Stage: IIIc","surgery status: optimal","taxane: 1","platinum: 1","pfs (m): 12","rec (1): 1","os (m): 49","death (1): 0","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM795nnn/GSM795058/GSM795058_s57d.txt.gz","41093"
"GSM795059","serous ovarian cancer 570d","GSM795059","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 3","Stage: IIIc","surgery status: suboptimal","taxane: 1","platinum: 1","pfs (m): 10","rec (1): 1","os (m): 12","death (1): 1","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM795nnn/GSM795059/GSM795059_s570d.txt.gz","41093"
"GSM795060","serous ovarian cancer 571d","GSM795060","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 3","Stage: IV","surgery status: suboptimal","taxane: 1","platinum: 1","pfs (m): 5","rec (1): 1","os (m): 21","death (1): 1","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM795nnn/GSM795060/GSM795060_s571d.txt.gz","41093"
"GSM795061","serous ovarian cancer 573d","GSM795061","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 3","Stage: IIIc","surgery status: suboptimal","taxane: 1","platinum: 1","pfs (m): 20","rec (1): 1","os (m): 44","death (1): 0","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM795nnn/GSM795061/GSM795061_s573d.txt.gz","41093"
"GSM795062","serous ovarian cancer 575d","GSM795062","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 3","Stage: IIIc","surgery status: suboptimal","taxane: 1","platinum: 1","pfs (m): 30","rec (1): 1","os (m): 30","death (1): 0","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM795nnn/GSM795062/GSM795062_s575d.txt.gz","41093"
"GSM795063","serous ovarian cancer 576d","GSM795063","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 3","Stage: IV","surgery status: suboptimal","taxane: 1","platinum: 1","pfs (m): 14","rec (1): 1","os (m): 30","death (1): 0","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM795nnn/GSM795063/GSM795063_s576d.txt.gz","41093"
"GSM795064","serous ovarian cancer 578d","GSM795064","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 3","Stage: IIIc","surgery status: suboptimal","taxane: 1","platinum: 1","pfs (m): 12","rec (1): 1","os (m): 28","death (1): 0","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM795nnn/GSM795064/GSM795064_s578d.txt.gz","41093"
"GSM795065","serous ovarian cancer 579d","GSM795065","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 2","Stage: IV","surgery status: optimal","taxane: 1","platinum: 1","pfs (m): 19","rec (1): 1","os (m): 27","death (1): 0","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM795nnn/GSM795065/GSM795065_s579d.txt.gz","41093"
"GSM795066","serous ovarian cancer 58d","GSM795066","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 2","Stage: IIIc","surgery status: optimal","taxane: 1","platinum: 1","pfs (m): 39","rec (1): 1","os (m): 46","death (1): 0","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM795nnn/GSM795066/GSM795066_s58d.txt.gz","41093"
"GSM795067","serous ovarian cancer 581d","GSM795067","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 2","Stage: IIIc","surgery status: suboptimal","taxane: 1","platinum: 1","pfs (m): 29","rec (1): 0","os (m): 29","death (1): 0","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM795nnn/GSM795067/GSM795067_s581d.txt.gz","41093"
"GSM795068","serous ovarian cancer 582d","GSM795068","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 3","Stage: IIIc","surgery status: suboptimal","taxane: 1","platinum: 1","pfs (m): 19","rec (1): 1","os (m): 47","death (1): 0","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM795nnn/GSM795068/GSM795068_s582d.txt.gz","41093"
"GSM795069","serous ovarian cancer 584d","GSM795069","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 2","Stage: IIIc","surgery status: optimal","taxane: 1","platinum: 1","pfs (m): 56","rec (1): 1","os (m): 73","death (1): 0","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM795nnn/GSM795069/GSM795069_s584d.txt.gz","41093"
"GSM795070","serous ovarian cancer 585d","GSM795070","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 3","Stage: IIIc","surgery status: suboptimal","taxane: 1","platinum: 1","pfs (m): 42","rec (1): 0","os (m): 42","death (1): 0","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM795nnn/GSM795070/GSM795070_s585d.txt.gz","41093"
"GSM795071","serous ovarian cancer 586d","GSM795071","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 2","Stage: IIIc","surgery status: suboptimal","taxane: 1","platinum: 1","pfs (m): 20","rec (1): 1","os (m): 44","death (1): 1","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM795nnn/GSM795071/GSM795071_s586d.txt.gz","41093"
"GSM795072","serous ovarian cancer 587d","GSM795072","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 3","Stage: IIIc","surgery status: optimal","taxane: 1","platinum: 1","pfs (m): 23","rec (1): 1","os (m): 35","death (1): 1","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM795nnn/GSM795072/GSM795072_s587d.txt.gz","41093"
"GSM795073","serous ovarian cancer 589d","GSM795073","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 3","Stage: IV","surgery status: suboptimal","taxane: 1","platinum: 1","pfs (m): 17","rec (1): 1","os (m): 27","death (1): 0","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM795nnn/GSM795073/GSM795073_s589d.txt.gz","41093"
"GSM795074","serous ovarian cancer 590d","GSM795074","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 3","Stage: IIIc","surgery status: suboptimal","taxane: 1","platinum: 1","pfs (m): 19","rec (1): 1","os (m): 54","death (1): 0","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM795nnn/GSM795074/GSM795074_s590d.txt.gz","41093"
"GSM795075","serous ovarian cancer 591d","GSM795075","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 3","Stage: IV","surgery status: suboptimal","taxane: 1","platinum: 1","pfs (m): 14","rec (1): 1","os (m): 49","death (1): 0","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM795nnn/GSM795075/GSM795075_s591d.txt.gz","41093"
"GSM795076","serous ovarian cancer 592d","GSM795076","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 3","Stage: IV","surgery status: suboptimal","taxane: 1","platinum: 1","pfs (m): 32","rec (1): 0","os (m): 32","death (1): 0","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM795nnn/GSM795076/GSM795076_s592d.txt.gz","41093"
"GSM795077","serous ovarian cancer 595d","GSM795077","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 3","Stage: IIIc","surgery status: suboptimal","taxane: 1","platinum: 1","pfs (m): 18","rec (1): 1","os (m): 48","death (1): 0","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM795nnn/GSM795077/GSM795077_s595d.txt.gz","41093"
"GSM795078","serous ovarian cancer 596d","GSM795078","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 2","Stage: IIIc","surgery status: optimal","taxane: 1","platinum: 1","pfs (m): 43","rec (1): 0","os (m): 43","death (1): 0","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM795nnn/GSM795078/GSM795078_s596d.txt.gz","41093"
"GSM795079","serous ovarian cancer 599d","GSM795079","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 3","Stage: IIIc","surgery status: suboptimal","taxane: 1","platinum: 1","pfs (m): 16","rec (1): 1","os (m): 36","death (1): 0","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM795nnn/GSM795079/GSM795079_s599d.txt.gz","41093"
"GSM795080","serous ovarian cancer 6d","GSM795080","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 3","Stage: IIIc","surgery status: optimal","taxane: 1","platinum: 1","pfs (m): 12","rec (1): 1","os (m): 32","death (1): 1","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM795nnn/GSM795080/GSM795080_s6d.txt.gz","41093"
"GSM795081","serous ovarian cancer 60d","GSM795081","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 2","Stage: IV","surgery status: suboptimal","taxane: 1","platinum: 1","pfs (m): 47","rec (1): 1","os (m): 103","death (1): 0","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM795nnn/GSM795081/GSM795081_s60d.txt.gz","41093"
"GSM795082","serous ovarian cancer 601d","GSM795082","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 3","Stage: IV","surgery status: suboptimal","taxane: 1","platinum: 1","pfs (m): 28","rec (1): 1","os (m): 34","death (1): 0","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM795nnn/GSM795082/GSM795082_s601d.txt.gz","41093"
"GSM795083","serous ovarian cancer 606d","GSM795083","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 2","Stage: IIIc","surgery status: suboptimal","taxane: 1","platinum: 1","pfs (m): 1","rec (1): 1","os (m): 5","death (1): 1","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM795nnn/GSM795083/GSM795083_s606d.txt.gz","41093"
"GSM795084","serous ovarian cancer 608d2","GSM795084","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 2","Stage: IIIc","surgery status: suboptimal","taxane: 1","platinum: 1","pfs (m): 53","rec (1): 0","os (m): 53","death (1): 0","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM795nnn/GSM795084/GSM795084_s608d2.txt.gz","41093"
"GSM795085","serous ovarian cancer 609dR","GSM795085","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 2","Stage: IIIc","surgery status: suboptimal","taxane: 1","platinum: 1","pfs (m): 47","rec (1): 0","os (m): 47","death (1): 0","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM795nnn/GSM795085/GSM795085_s609dR.txt.gz","41093"
"GSM795086","serous ovarian cancer 61d","GSM795086","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 2","Stage: IIIc","surgery status: suboptimal","taxane: 1","platinum: 1","pfs (m): 26","rec (1): 1","os (m): 74","death (1): 1","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM795nnn/GSM795086/GSM795086_s61d.txt.gz","41093"
"GSM795087","serous ovarian cancer 610d2","GSM795087","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 2","Stage: IIIc","surgery status: suboptimal","taxane: 1","platinum: 1","pfs (m): 69","rec (1): 0","os (m): 69","death (1): 0","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM795nnn/GSM795087/GSM795087_s610d2.txt.gz","41093"
"GSM795088","serous ovarian cancer 611d","GSM795088","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 2","Stage: IIIc","surgery status: suboptimal","taxane: 1","platinum: 1","pfs (m): 41","rec (1): 1","os (m): 50","death (1): 0","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM795nnn/GSM795088/GSM795088_s611d.txt.gz","41093"
"GSM795089","serous ovarian cancer 612d2","GSM795089","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 3","Stage: IIIc","surgery status: suboptimal","taxane: 1","platinum: 1","pfs (m): 12","rec (1): 1","os (m): 32","death (1): 1","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM795nnn/GSM795089/GSM795089_s612d2.txt.gz","41093"
"GSM795090","serous ovarian cancer 613d2","GSM795090","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 2","Stage: IV","surgery status: suboptimal","taxane: 1","platinum: 1","pfs (m): 19","rec (1): 1","os (m): 30","death (1): 1","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM795nnn/GSM795090/GSM795090_s613d2.txt.gz","41093"
"GSM795091","serous ovarian cancer 616d2","GSM795091","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 2","Stage: IIIc","surgery status: suboptimal","taxane: 1","platinum: 1","pfs (m): 25","rec (1): 1","os (m): 59","death (1): 0","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM795nnn/GSM795091/GSM795091_s616d2.txt.gz","41093"
"GSM795092","serous ovarian cancer 62d","GSM795092","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 2","Stage: IIIc","surgery status: suboptimal","taxane: 1","platinum: 1","pfs (m): 11","rec (1): 1","os (m): 26","death (1): 1","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM795nnn/GSM795092/GSM795092_s62d.txt.gz","41093"
"GSM795093","serous ovarian cancer 621d2","GSM795093","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 2","Stage: IIIc","surgery status: suboptimal","taxane: 1","platinum: 1","pfs (m): 38","rec (1): 1","os (m): 49","death (1): 1","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM795nnn/GSM795093/GSM795093_s621d2.txt.gz","41093"
"GSM795094","serous ovarian cancer 623d2","GSM795094","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 2","Stage: IIIc","surgery status: optimal","taxane: 1","platinum: 1","pfs (m): 25","rec (1): 1","os (m): 30","death (1): 0","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM795nnn/GSM795094/GSM795094_s623d2.txt.gz","41093"
"GSM795095","serous ovarian cancer 628d2","GSM795095","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 2","Stage: IV","surgery status: suboptimal","taxane: 1","platinum: 1","pfs (m): 22","rec (1): 0","os (m): 22","death (1): 0","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM795nnn/GSM795095/GSM795095_s628d2.txt.gz","41093"
"GSM795096","serous ovarian cancer 630d2","GSM795096","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 2","Stage: IIIc","surgery status: optimal","taxane: 1","platinum: 1","pfs (m): 10","rec (1): 1","os (m): 43","death (1): 1","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM795nnn/GSM795096/GSM795096_s630d2.txt.gz","41093"
"GSM795097","serous ovarian cancer 633d2R","GSM795097","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 2","Stage: IIIc","surgery status: suboptimal","taxane: 1","platinum: 1","pfs (m): 10","rec (1): 1","os (m): 64","death (1): 1","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM795nnn/GSM795097/GSM795097_s633d2R.txt.gz","41093"
"GSM795098","serous ovarian cancer 634d2","GSM795098","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 2","Stage: IIIc","surgery status: optimal","taxane: 1","platinum: 1","pfs (m): 19","rec (1): 1","os (m): 61","death (1): 1","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM795nnn/GSM795098/GSM795098_s634d2.txt.gz","41093"
"GSM795099","serous ovarian cancer 635d2","GSM795099","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 2","Stage: IIIc","surgery status: suboptimal","taxane: 1","platinum: 1","pfs (m): 30","rec (1): 1","os (m): 48","death (1): 1","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM795nnn/GSM795099/GSM795099_s635d2.txt.gz","41093"
"GSM795100","serous ovarian cancer 636d2R","GSM795100","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 2","Stage: IIIc","surgery status: suboptimal","taxane: 1","platinum: 1","pfs (m): 19","rec (1): 1","os (m): 40","death (1): 1","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM795nnn/GSM795100/GSM795100_s636d2R.txt.gz","41093"
"GSM795101","serous ovarian cancer 637d","GSM795101","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 2","Stage: IIIc","surgery status: suboptimal","taxane: 1","platinum: 1","pfs (m): 11","rec (1): 1","os (m): 12","death (1): 1","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM795nnn/GSM795101/GSM795101_s637d.txt.gz","41093"
"GSM795102","serous ovarian cancer 64d","GSM795102","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 2","Stage: IIIc","surgery status: optimal","taxane: 1","platinum: 1","pfs (m): 50","rec (1): 0","os (m): 50","death (1): 0","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM795nnn/GSM795102/GSM795102_s64d.txt.gz","41093"
"GSM795103","serous ovarian cancer 641d2","GSM795103","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 2","Stage: IIIc","surgery status: suboptimal","taxane: 1","platinum: 1","pfs (m): 119","rec (1): 0","os (m): 119","death (1): 0","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM795nnn/GSM795103/GSM795103_s641d2.txt.gz","41093"
"GSM795104","serous ovarian cancer 642d","GSM795104","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 2","Stage: IIIc","surgery status: optimal","taxane: 1","platinum: 1","pfs (m): 12","rec (1): 0","os (m): 12","death (1): 0","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM795nnn/GSM795104/GSM795104_s642d.txt.gz","41093"
"GSM795105","serous ovarian cancer 643d","GSM795105","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 2","Stage: IIIb","surgery status: optimal","taxane: 1","platinum: 1","pfs (m): 21","rec (1): 0","os (m): 21","death (1): 0","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM795nnn/GSM795105/GSM795105_s643d.txt.gz","41093"
"GSM795106","serous ovarian cancer 644d","GSM795106","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 2","Stage: IIIc","surgery status: suboptimal","taxane: 1","platinum: 1","pfs (m): 23","rec (1): 0","os (m): 23","death (1): 0","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM795nnn/GSM795106/GSM795106_s644d.txt.gz","41093"
"GSM795107","serous ovarian cancer 66d","GSM795107","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 2","Stage: IIIc","surgery status: optimal","taxane: 1","platinum: 1","pfs (m): 19","rec (1): 1","os (m): 31","death (1): 1","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM795nnn/GSM795107/GSM795107_s66d.txt.gz","41093"
"GSM795108","serous ovarian cancer 68d","GSM795108","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 2","Stage: IIIa","surgery status: optimal","taxane: 1","platinum: 1","pfs (m): 46","rec (1): 0","os (m): 46","death (1): 0","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM795nnn/GSM795108/GSM795108_s68d.txt.gz","41093"
"GSM795109","serous ovarian cancer 69d","GSM795109","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 2","Stage: IIIb","surgery status: optimal","taxane: 1","platinum: 1","pfs (m): 45","rec (1): 0","os (m): 45","death (1): 0","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM795nnn/GSM795109/GSM795109_s69d.txt.gz","41093"
"GSM795110","serous ovarian cancer 7d","GSM795110","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 2","Stage: IIIa","surgery status: optimal","taxane: 1","platinum: 1","pfs (m): 19","rec (1): 1","os (m): 42","death (1): 1","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM795nnn/GSM795110/GSM795110_s7d.txt.gz","41093"
"GSM795111","serous ovarian cancer 72d","GSM795111","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 2","Stage: IIIb","surgery status: optimal","taxane: 1","platinum: 1","pfs (m): 13","rec (1): 1","os (m): 26","death (1): 1","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM795nnn/GSM795111/GSM795111_s72d.txt.gz","41093"
"GSM795112","serous ovarian cancer 77d","GSM795112","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 3","Stage: IIIc","surgery status: suboptimal","taxane: 1","platinum: 1","pfs (m): 1","rec (1): 1","os (m): 1","death (1): 1","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM795nnn/GSM795112/GSM795112_s77d.txt.gz","41093"
"GSM795113","serous ovarian cancer 79d","GSM795113","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 3","Stage: IIIc","surgery status: optimal","taxane: 1","platinum: 1","pfs (m): 16","rec (1): 1","os (m): 27","death (1): 1","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM795nnn/GSM795113/GSM795113_s79d.txt.gz","41093"
"GSM795114","serous ovarian cancer 80d","GSM795114","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 3","Stage: IIIc","surgery status: suboptimal","taxane: 1","platinum: 1","pfs (m): 12","rec (1): 1","os (m): 79","death (1): 1","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM795nnn/GSM795114/GSM795114_s80d.txt.gz","41093"
"GSM795115","serous ovarian cancer 84d","GSM795115","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 3","Stage: IV","surgery status: suboptimal","taxane: 1","platinum: 1","pfs (m): 16","rec (1): 1","os (m): 46","death (1): 1","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM795nnn/GSM795115/GSM795115_s84d.txt.gz","41093"
"GSM795116","serous ovarian cancer 86d","GSM795116","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 3","Stage: IIIc","surgery status: optimal","taxane: 1","platinum: 1","pfs (m): 94","rec (1): 0","os (m): 94","death (1): 0","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM795nnn/GSM795116/GSM795116_s86d.txt.gz","41093"
"GSM795117","serous ovarian cancer 88d","GSM795117","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 2","Stage: IV","surgery status: optimal","taxane: 1","platinum: 1","pfs (m): 51","rec (1): 1","os (m): 86","death (1): 1","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM795nnn/GSM795117/GSM795117_s88d.txt.gz","41093"
"GSM795118","serous ovarian cancer 89d","GSM795118","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 3","Stage: IV","surgery status: suboptimal","taxane: 1","platinum: 1","pfs (m): 13","rec (1): 1","os (m): 33","death (1): 1","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM795nnn/GSM795118/GSM795118_s89d.txt.gz","41093"
"GSM795119","serous ovarian cancer 90d","GSM795119","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 3","Stage: IIIc","surgery status: suboptimal","taxane: 1","platinum: 1","pfs (m): 29","rec (1): 1","os (m): 51","death (1): 1","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM795nnn/GSM795119/GSM795119_s90d.txt.gz","41093"
"GSM795120","serous ovarian cancer 92d","GSM795120","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 2","Stage: IV","surgery status: suboptimal","taxane: 1","platinum: 1","pfs (m): 3","rec (1): 1","os (m): 54","death (1): 1","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM795nnn/GSM795120/GSM795120_s92d.txt.gz","41093"
"GSM795121","serous ovarian cancer 93d","GSM795121","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 2","Stage: IIIb","surgery status: optimal","taxane: 1","platinum: 1","pfs (m): 75","rec (1): 0","os (m): 75","death (1): 0","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM795nnn/GSM795121/GSM795121_s93d.txt.gz","41093"
"GSM795122","serous ovarian cancer 94d","GSM795122","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 2","Stage: IV","surgery status: optimal","taxane: 1","platinum: 1","pfs (m): 20","rec (1): 1","os (m): 57","death (1): 0","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM795nnn/GSM795122/GSM795122_s94d.txt.gz","41093"
"GSM795123","serous ovarian cancer 95d","GSM795123","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 2","Stage: IIIc","surgery status: optimal","taxane: 1","platinum: 1","pfs (m): 4","rec (1): 1","os (m): 42","death (1): 0","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM795nnn/GSM795123/GSM795123_s95d.txt.gz","41093"
"GSM795124","serous ovarian cancer 97d","GSM795124","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: high-grade serous ovarian cancer tumor","grading: 2","Stage: IV","surgery status: suboptimal","taxane: 1","platinum: 1","pfs (m): 8","rec (1): 1","os (m): 28","death (1): 0","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565CA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.10.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM795nnn/GSM795124/GSM795124_s97d.txt.gz","41093"
